Potassium iodide is an antithyroid agent used for the preoperative management of hyperthyroidism in patients with Graves’ disease undergoing thyroidectomy. It is used in the management of severe, life-threatening thyrotoxicosis in conjunction with other antithyroid agents, β-adrenergic blocking agents, and corticosteroids. Potassium iodide is also used for the blockage of thyroidal uptake of radioactive isotopes of iodine that may be released into the environment (for instance from a nuclear power plant) to minimize the risk of radiation induced thyroid neoplasms related to internal exposures to radioiodine. It is used to protect the thyroid gland during diagnostic or therapeutic use of radiopharmaceuticals or drugs that have radioactive components. Potassium iodide is used for the treatment of cutaneous sporotrichosis and lymphocutaneous sporotrichosis caused by Sporothrix schenckii. Potassium iodide has been used as an expectorant in the symptomatic management of chronic pulmonary diseases where tenacious mucus complicated the condition.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Potassium Iodide, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.